HSD17β11 is most highly enriched in the liver (27) and dysregulated triglyceride metabolism is a hallmark of hepatic steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD). This evidence concerns the gene HSD17B11 and metabolic dysfunction-associated steatotic liver disease.